Read Our Blog Posts

Selank Peptide: Dosage, Benefits & Results (2026 Guide)

Selank is a synthetic heptapeptide analog of tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) synthesized in Russia and studied extensively for its anxiolytic, nootropic, immunomodulatory and stress-protective effects in laboratory as well as limited clinical models. It is involved in modulating enkephalin degradation, upregulating BDNF expression, modulating GABAergic neurotransmission, and altering the serotonergic and dopaminergic systems, thereby reducing anxiety-like behavior and promoting cognitive adaptation in experimental studies.

Selank has been shown to modify the expression of genes involved in immune response, inflammation regulation, and neuronal plasticity, as well as generalized anxiety, chronic stress, alcohol withdrawal, and immune dysregulation models. The FDA has not approved it for any therapeutic use, and in the United States, it remains an investigational compound.

Note: Selank is not FDA-approved for human consumption yet; it’s currently in use only in research studies.)

Are You Interested in Researching Selank? Order Now!

How Does Selank Work: What Research Studies Find?

Alterations in the central nervous system primarily mediate the effects of Selank. It inhibits enkephalin-degrading enzymes and is therefore likely to increase endogenous opioid tone, contributing to its anxiolytic features. Studies have shown that Selank modulates levels of brain-derived neurotrophic factor (BDNF) and its receptor, TrkB, in key brain regions, including the hippocampus and prefrontal cortex, thereby supporting synaptic plasticity and neuronal resilience.

It modulates GABAergic neurotransmission by regulating gene expression of GABA receptor subunits and associated transporters. Selank regulates serotonin and dopamine without causing hormonal side effects. It also normalizes enkephalin and serotonin levels, lowers inflammation markers (e.g., IL-6), and promotes adaptation to chronic mild stress or alcohol withdrawal in stress models.

In rat models, genome-wide analysis shows Selank regulates genes relevant for immune response, vascular function, and neurorepair. Flexible Installment Plan For Lending Multiple Collects for Niche Partners

Therefore, these mechanisms render Selank a tool for studying the pathways of anxiety-related behavior, emotional regulation in the CNS, neurotrophic support, and immune–CNS interactions under controlled laboratory conditions.

Selank Benefits (in research environment)

Selank has been investigated in numerous preclinical and early clinical studies. Key observations from studies include:

1. Reduces Anxiety-Like Behavior

In rodent models (elevated plus-maze and open-field tests), Selank reduces signs of anxiety without sedative or muscle-relaxant effects. It also prevents mechanical allodynia and emotional dysregulation, through normalizing behaviors in chronic mild stress and alcohol withdrawal paradigms.

2. Enhances Cognitive and Learning Markers

Selank is a known enhancer of attention, memory consolidation, and learning efficiency in behavioral paradigms. It aids in the rapid acquisition of conditioned responses. It improves retention during tasks that measure activity in mazes or object recognition. Moderate nootropic effects are found when exposed to stressors.

3. Upregulates BDNF and Neurotrophic Pathways

Selank also induces BDNF and TrkB expressions in the hippocampus and prefrontal cortex, enhancing synaptic plasticity, dendritic remodeling, and neuronal survival. This promotes cognitive resilience and long-term potentiation in laboratory animals.

4. Modulates Stress Response and Adaptation

In prolonged stress, Selank brought enkephalin and serotonin levels into the normal range, reduced anxiety-like behavior, and increased emotional stability. It promotes the adaptation to unpredictable mild stress, suppressing hyperactivity induced by opiate withdrawal.

5. Supports Immunomodulation and Anti-Inflammatory Effects

Selank modulates IL-6 pathways through reduction of pro-inflammatory signalling and maintenance of immune homeostasis in models of immune challenge or stress. It has newborn- and user-induced doping effects, which may correct immune dysregulation and inflammation-related neuronal alterations.

Disclaimer: These benefits are still to be tested on human beings; mostly limited to studies in animals or other research models. Selank is not FDA-approved for human consumption.

Start your research with Selank now!

Selank Dosage: Under Research Conditions

Medically, Selank is typically provided as a lyophilized powder for research purposes (e.g., 10 mg or 30 mg vials) and reconstituted for laboratory use. Studies use low doses to activate specific pathways, with limited nonspecific effects.

Standard Quantitative Range

Active doses in preclinical animal studies: 100–600 μg/kg (intranasal or systemic)
Typical research dose: 200–500 μg/kg per administration
Goal: Obtain anxiolytic/neurotrophic signaling w/o overstimulation

Initial Calibration (Baseline Phase)

Initial dose: Low end (e.g., 100–300 μg/kg intranasal)
Dosage: either as a single or repeated low-dose administration
Justification: Ace dose-response curve, prevents acute behavioral or biochemical changes, and prohibits desensitization

Maintenance and Longitudinal Observation

Dose: Target dosing is 300–500 μg/kg per day or every other day
Treatment duration: 5–14 days in chronic models; up to 4–8 weeks in longitudinal studies.
Rationale: Facilitate ongoing, steady-state modulation of enkephalin, BDNF and GABA systems; monitor cumulative effects across time on behavior and gene expression

Research Application of Selank: Preparation and Use

This is important because improper reconstitution and handling can cause peptide instability, resulting in inaccurate experimental results.

1. Supplies Needed Before Mixing

Bottle of Selank (e.g., 10 mg or 30 mg lyophilized)
Sterile bacteriostatic water or normal saline
Alcohol swabs
Sterile syringe (insulin syringe, etc.)
Clean, sanitized workspace

2. Step-by-Step Reconstitution Process

Before drawing, wipe the vial tops with alcohol swabs.
Draw an appropriate amount of bacteriostatic water into a syringe (usually between 1 and 2 mL, depending on vial size).
Inject water slowly along the wall of the vial to avoid foaming.
Gently swirl (do not shake) until fully dissolved and the solution is clear.
Store reconstituted vial at 2–8°C and protect from light

Selank: Anticipated Timeline and Outcomes

Research timelines differ by model, route, dose, and endpoint. Effects are usually seen quickly because the drug has a direct CNS action and is an enkephalin-engendered affecting agent.

Phase 1: Initial Response (Days 1–7)

Acute modulation of enkephalin, serotonin, and GABA systems
Significant reductions in anxiety-like behavior and biomarkers of stress
Rapid BDNF upregulation and gene regulatory changes in an animal model of stress